Three Cases of Familial Moyamoya Disease with RASA1 Mutations-A Case Report

World Neurosurg. 2022 Nov:167:e972-e977. doi: 10.1016/j.wneu.2022.08.118. Epub 2022 Sep 3.

Abstract

Objective: The prevalence of moyamoya disease (MMD) is relatively high in East Asia, whereas the susceptibility genes of MMD have not been identified.

Methods: Here, we reported 3 patients diagnosed with MMD from 1 single family, including a 53-year-old mother (case 1) and her 32-year-old and 29-year-old daughters (cases 2 and 3). The younger daughter was diagnosed with cerebral hemorrhage. Computed tomographic angiogram showed the typical signs of MMD in 3 patients.

Results: Clinical whole-exome sequencing was performed in 3 daughters of case 1, and RASA1 mutations in chr5: 87,376,389 and NM_002890.2: c.2012-4C > T were determined to have the strongest correlation with MMD. RASA1 mutations were verified in case 1, husband of case 1 and the descendant of case 3 by using Sanger sequencing.

Conclusions: According to the findings of literature review, this is the first study indicating the association between RASA1 mutations and MMD.

Keywords: Case report; Computed tomographic angiogram; Familial moyamoya disease; Moyamoya disease; RASA1.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cerebral Hemorrhage / diagnostic imaging
  • Cerebral Hemorrhage / genetics
  • Female
  • Genetic Predisposition to Disease / genetics
  • Humans
  • Middle Aged
  • Moyamoya Disease* / genetics
  • Mutation / genetics
  • p120 GTPase Activating Protein* / genetics

Substances

  • p120 GTPase Activating Protein
  • RASA1 protein, human

Supplementary concepts

  • Moyamoya disease 1